Biblio
“Genetic control of human brain transcript expression in Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 4, pp. 445-58, 2009.
, “Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.”, Nat Genet, vol. 45, no. 12, pp. 1452-8, 2013.
, “SORL1 variants across Alzheimer's disease European American cohorts.”, Eur J Hum Genet, vol. 24, no. 12, pp. 1828-1830, 2016.
, “Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.”, Hum Mol Genet, vol. 12, no. 24, pp. 3259-67, 2003.
, “The ubiquilin 1 gene and Alzheimer's disease.”, N Engl J Med, vol. 352, no. 26, pp. 2752-3; author reply 2752-3, 2005.
, “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.”, JAMA, vol. 309, no. 14, pp. 1483-92, 2013.
, “Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.”, Am J Hum Genet, vol. 83, no. 5, pp. 623-32, 2008.
, “Genome-wide association analysis of age-at-onset in Alzheimer's disease.”, Mol Psychiatry, vol. 17, no. 12, pp. 1340-6, 2012.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.”, Neurogenetics, vol. 9, no. 1, pp. 51-60, 2008.
, “Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.”, Genome Med, vol. 10, no. 1, p. 43, 2018.
, “A survey of genetic human cortical gene expression.”, Nat Genet, vol. 39, no. 12, pp. 1494-9, 2007.
, “Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.”, Neurosci Lett, vol. 381, no. 1-2, pp. 36-41, 2005.
, “Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.”, Neurogenetics, vol. 11, no. 3, pp. 335-48, 2010.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “A comprehensive genetic association study of Alzheimer disease in African Americans.”, Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
, “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.
, “Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”, PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.
, “Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.”, Hum Mol Genet, vol. 24, no. 12, pp. 3557-70, 2015.
, “Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.”, PLoS Genet, vol. 6, no. 9, p. e1001130, 2010.
, “Analysis of European mitochondrial haplogroups with Alzheimer disease risk.”, Neurosci Lett, vol. 365, no. 1, pp. 28-32, 2004.
, “Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.”, Hum Mol Genet, vol. 19, no. 10, pp. 2068-78, 2010.
, “Genetic association of low density lipoprotein receptor and Alzheimer's disease.”, Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.
,